ABERRANT HYPEREDITING OF MYELOMA TRANSCRIPTOME BY ADAR1 CONFERS ONCOGENICITY AND IS A MARKER OF POOR PROGNOSIS. (12th June 2019) - Teoh, P.; An, O.; Chung, T.; Chooi, J.; Toh, S.; Fan, S.; Wang, W.; Koh, B.; Fullwood, M.; Ooi, M.; de Mel, S.; Soekojo, C.; et al.